Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Russia Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20045
20052
20064
20076
20086
20091
20108
20117
20125
20136
20141
20164
20175
20196
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61
Terminated7
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.13
Sumitomo Pharma America, Inc.9
Alkermes, Inc.5
Eli Lilly and Company5
Janssen Research & Development, LLC5
AstraZeneca4
H. Lundbeck A/S4
Hoffmann-La Roche4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4
ACADIA Pharmaceuticals Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia69
Psychotic Disorders5
Bipolar Disorder3
Cognition Disorders3
Mental Disorders2
Autistic Disorder1
Mania1
Recurrence1

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.